Nacer Abrouk

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

Tony Reid, Bryan Oronsky, Jan Scicinski et al. · The Lancet Oncology · 2015 · 90 citations

Pharmacy, Oncology, Pharmacology +12

REPLATINUM Phase III Randomized Study: RRx-001 + Platinum Doublet Versus Platinum Doublet in Third-Line Small Cell Lung Cancer

Bryan Oronsky, Tony R. Reid, Christopher Larson et al. · Future Oncology · 2019 · 51 citations

Medicine, Oncology, Pharmacology +11

Safety and efficacy of extended‐release bupivacaine local anaesthetic in open hernia repair: a randomized controlled trial

Afif Hadj, Andrew K. Hadj, Andrew K. Hadj et al. · ANZ Journal of Surgery · 2011 · 38 citations

Medicine, Anesthesiology, Surgery +16

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Yusuke Tomita, Bryan Oronsky, Nacer Abrouk et al. · Translational Lung Cancer Research · 2021 · 21 citations · Full text

Medicine, Immunology, Oncology +17

Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME)

Tony Reid, Bryan Oronsky, Scott Caroen et al. · Frontiers in Immunology · 2023 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17